Biodexa Pharmaceuticals's total assets for Q2 2024 were £13.97M, an increase of 32.50% from the previous quarter. BDRX total liabilities were £5.24M for the fiscal quarter, a -10.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.